Nanoco pioneers Quantum Dot innovation for mass market success

Nanoco stands at the forefront of quantum dot technology, delivering customised solutions from initial research to full-scale commercial production. With a unique position in the industry, the company enables seamless integration of cutting-edge nanomaterials into high-growth consumer markets.

Nanoco’s state-of-the-art sensing facility can produce materials for hundreds of millions of consumer electronics devices, ensuring scalability for industry leaders. Meanwhile, its advanced display facility meets the demand for approximately one million 65” televisions or nearly 100 million smartphones, demonstrating its capacity to support global market needs.

Partnering with Nanoco guarantees a smooth transition from innovation to production, adhering to the highest industry standards. With a commitment to quality, reliability, and efficiency, Nanoco empowers businesses with next-generation quantum dot solutions that enhance product performance and market competitiveness.

Nanoco Group PLC (LON:NANO) leads the world in the research, development and large-scale manufacture of heavy metal-free nanomaterials for use in displays, lighting, vertical farming, solar energy and bio-imaging.

Click to view all articles for the EPIC:
Or click to view the full company profile:
Facebook
X
LinkedIn
Nanoco Group PLC

More articles like this

Nanoco Group PLC

Quantum Dots could revolutionise your portfolio

Unlock the potential of quantum dots – microscopic particles revolutionizing industries with vibrant displays, efficient sensors, and advanced medical tools. Experience the economic opportunities with Nanoco Group PLC.

Nanoco Group PLC

QDs: Harnessing Quantum Confinement

Explore the groundbreaking research on colloidal quantum dots and their ability to control photochemical reactions through quantum coherence.

Nanoco Group PLC

The promise of Quantum Dots

Quantum dots (QDs) represent a significant advancement in nanotechnology, finding applications across diverse fields. In bioimaging, their small size enables them to access almost any part of the body, making them ideal for tasks like medical

Nanoco Group PLC

Nanoco publishes 2024 Annual Report, confirms £46m IP value

Nanoco Group plc (LON:NANO) has confirmed that its Annual Report and Accounts for the financial year ended 31 July 2024 has been made available to shareholders. Shareholders opting out of electronic communication will receive a paper copy